COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Giovanni Novi, Małgorzata Mikulska, Federica Briano, Federica Toscanini, Francesco Tazza, Antonio Uccelli, Matilde Inglese
Topics & Concepts
OcrelizumabMedicineImmunosuppressionMultiple sclerosisCoronavirus disease 2019 (COVID-19)DiseaseImmune systemImmunologyInternal medicineRituximabInfectious disease (medical specialty)AntibodyLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies